Logout 
India vs Big Pharma: Compulsory licence for leukaemia drug sought
India vs Big Pharma: Compulsory licence for leukaemia drug sought
India vs Big Pharma: Compulsory licence for leukaemia drug sought
'Compulsory licence verdict a triumph for humanity'
Experts believe that this case will set a precedent for all future legal tangles between Big Pharma and the country as a marker of how cases pertaining to drug patents will be played out in the country.
What Monica Lewinsky and Indian generic drugs have in common – Bill Clinton loves them both
Novartis not optimistic about Supreme Court verdict
Leading lawyer calls India's pharma sector 'hip and hapenning'
Judges tell Novartis at Rs 1.2 lakh a month, drugs too expensive for them!
SC asks Novartis to reduce drug price - again!
Intellectual property board hears Bayer vs compulsory licencing case, verdict awaited
"Novartis win will have an adverse impact on the access to treatment"
Pathbreaking case - India Vs Big Pharma - in Supreme Court tomorrow
'Compulsory licence' to Natco will bring down cost of cancer drug by 97%
Compulsory licensing effect: Cipla slashes price of generic cancer drug by 80%!
India vs Big Pharma: Compulsory licence for leukaemia drug sought
'Compulsory licence verdict a triumph for humanity'
Experts believe that this case will set a precedent for all future legal tangles between Big Pharma and the country as a marker of how cases pertaining to drug patents will be played out in the country.
What Monica Lewinsky and Indian generic drugs have in common – Bill Clinton loves them both
Novartis not optimistic about Supreme Court verdict
Leading lawyer calls India's pharma sector 'hip and hapenning'
Judges tell Novartis at Rs 1.2 lakh a month, drugs too expensive for them!
SC asks Novartis to reduce drug price - again!
Intellectual property board hears Bayer vs compulsory licencing case, verdict awaited
"Novartis win will have an adverse impact on the access to treatment"
Pathbreaking case - India Vs Big Pharma - in Supreme Court tomorrow
'Compulsory licence' to Natco will bring down cost of cancer drug by 97%
Compulsory licensing effect: Cipla slashes price of generic cancer drug by 80%!
